Pierre Schneider

541 total citations
20 papers, 343 citations indexed

About

Pierre Schneider is a scholar working on Oncology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Pierre Schneider has authored 20 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 5 papers in Pathology and Forensic Medicine and 5 papers in Epidemiology. Recurrent topics in Pierre Schneider's work include Cutaneous Melanoma Detection and Management (5 papers), Melanoma and MAPK Pathways (4 papers) and CAR-T cell therapy research (3 papers). Pierre Schneider is often cited by papers focused on Cutaneous Melanoma Detection and Management (5 papers), Melanoma and MAPK Pathways (4 papers) and CAR-T cell therapy research (3 papers). Pierre Schneider collaborates with scholars based in France, United States and Germany. Pierre Schneider's co-authors include M. Viguier, Célèste Lebbé, Cécile Pagès, M. Bagot, Nicole Basset‐Séguin, Charlotte Hurabielle, Beth Beilfuss, Joan Guitart, J. Roux and Raymond L. Barnhill and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Pierre Schneider

20 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Schneider France 12 163 90 87 75 67 20 343
Marı́a Niveiro Spain 11 134 0.8× 59 0.7× 80 0.9× 46 0.6× 46 0.7× 35 413
Thomas L. Cibull United States 11 139 0.9× 166 1.8× 76 0.9× 61 0.8× 96 1.4× 32 388
Bénédicte Deau France 12 169 1.0× 190 2.1× 72 0.8× 57 0.8× 56 0.8× 43 476
Eun Bong Lee South Korea 11 64 0.4× 76 0.8× 70 0.8× 214 2.9× 77 1.1× 14 509
Andre M. Kallab United States 9 92 0.6× 49 0.5× 64 0.7× 39 0.5× 67 1.0× 17 285
Krista Kuuliala Finland 11 140 0.9× 34 0.4× 66 0.8× 53 0.7× 21 0.3× 26 394
Zimu Gong United States 11 243 1.5× 36 0.4× 42 0.5× 93 1.2× 45 0.7× 35 399
H. Jouhadi Morocco 12 215 1.3× 89 1.0× 111 1.3× 62 0.8× 70 1.0× 92 472
Pamela Ely United States 10 49 0.3× 69 0.8× 85 1.0× 99 1.3× 19 0.3× 22 377
Ray Lonsdale United Kingdom 11 68 0.4× 31 0.3× 44 0.5× 86 1.1× 34 0.5× 22 306

Countries citing papers authored by Pierre Schneider

Since Specialization
Citations

This map shows the geographic impact of Pierre Schneider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Schneider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Schneider more than expected).

Fields of papers citing papers by Pierre Schneider

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Schneider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Schneider. The network helps show where Pierre Schneider may publish in the future.

Co-authorship network of co-authors of Pierre Schneider

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Schneider. A scholar is included among the top collaborators of Pierre Schneider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Schneider. Pierre Schneider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Osio, Amélie, Pierre Schneider, Philippe Moguelet, et al.. (2020). Spindle cell tumor with CD34 and S100 co‐expression and distinctive stromal and perivascular hyalinization showing EML4‐ALK fusion. Journal of Cutaneous Pathology. 48(7). 896–901. 21 indexed citations
2.
Alexandre, M., G. Bohelay, Françoise Aucouturier, et al.. (2018). Gliptin Accountability in Mucous Membrane Pemphigoid Induction in 24 Out of 313 Patients. Frontiers in Immunology. 9. 1030–1030. 25 indexed citations
3.
Schneider, Pierre, et al.. (2017). IgG4-Related Disease With Orbital Pseudotumors Treated With Rituximab Combined With Palpebral Surgery. JAMA Dermatology. 153(3). 355–355. 11 indexed citations
4.
Gottlieb, J., S. Oro, M. Alexandre, et al.. (2016). Idiopathic linear IgA bullous dermatosis: prognostic factors based on a case series of 72 adults. British Journal of Dermatology. 177(1). 212–222. 34 indexed citations
5.
Hurabielle, Charlotte, Évangéline Pillebout, Thomas Stehlé, et al.. (2016). Mechanisms Underpinning Increased Plasma Creatinine Levels in Patients Receiving Vemurafenib for Advanced Melanoma. PLoS ONE. 11(3). e0149873–e0149873. 23 indexed citations
6.
Chasset, François, Cécile Pagès, Lucie Biard, et al.. (2015). Single-center study under a French Temporary Authorization for Use (TAU) protocol for ipilimumab in metastatic melanoma: negative impact of baseline corticosteroids. European Journal of Dermatology. 25(1). 36–44. 35 indexed citations
7.
Hurabielle, Charlotte, Pierre Schneider, Clotilde Baudry, et al.. (2015). Certolizumab pegol – A new therapeutic option for refractory disseminated pyoderma gangrenosum associated with Crohn’s disease. Journal of Dermatological Treatment. 27(1). 67–69. 23 indexed citations
8.
Velter, C., Cécile Pagès, Pierre Schneider, et al.. (2014). Four cases of rituximab-associated melanoma. Melanoma Research. 24(4). 401–403. 15 indexed citations
9.
Chasset, François, Cécile Pagès, Lucie Biard, et al.. (2014). Single-center experience in French Temporary Authorization for Use (TAU) metastatic melanoma program with ipilimumab.. Journal of Clinical Oncology. 32(15_suppl). e20034–e20034. 3 indexed citations
10.
Verneuil, L., Mariana Varna, Philippe Ratajczak, et al.. (2013). Human skin carcinoma arising from kidney transplant–derived tumor cells. Journal of Clinical Investigation. 123(9). 3797–3801. 10 indexed citations
11.
Pagès, Cécile, Pierre Schneider, M. Viguier, et al.. (2013). Vemurafenib in the French temporary authorization for use metastatic melanoma cohort. Melanoma Research. 24(1). 75–82. 15 indexed citations
12.
Monfort, J.‐B., Cécile Pagès, Pierre Schneider, et al.. (2012). Vemurafenib-induced neutrophilic panniculitis. Melanoma Research. 22(5). 399–401. 33 indexed citations
13.
Schneider, Pierre, Gentiane Monsel, Nicolas Véziris, et al.. (2011). Successful treatment of nodular lymphangitis due to in two immunosuppressed patients. Dermatology Online Journal. 17(3). 4 indexed citations
14.
Schneider, Pierre, Gentiane Monsel, Nicolas Véziris, et al.. (2011). Successful treatment of nodular lymphangitis due to Mycobacterium chelonae in two immunosuppressed patients.. PubMed. 17(3). 8–8. 6 indexed citations
15.
Gerami, Pedram, Raymond L. Barnhill, Beth Beilfuss, et al.. (2010). Superficial Melanocytic Neoplasms With Pagetoid Melanocytosis. The American Journal of Surgical Pathology. 34(6). 816–821. 28 indexed citations
16.
Beck, Christian, et al.. (2009). How can calcium pyrophosphate crystals induce inflammation in hypophosphatasia or chronic inflammatory joint diseases?. Klinische Pädiatrie. 221(2). 3 indexed citations
17.
Vallböhmer, Daniel, Stephan Baldus, Jan Brabender, et al.. (2008). Comparative analysis of four histopathological classification systems to discriminate benign and malignant behaviour in gastrointestinal stromal tumors.. PubMed. 28(1B). 367–72. 7 indexed citations
18.
Vasse, Marc, et al.. (2001). Fibronectin increases the migration induced by stromal cell-derived factor-1 alpha (SDF-1 alpha) in pre-B acute lymphoblastic leukemia cells.. PubMed. 12(2). 223–30. 12 indexed citations
19.
Michel, Gérard, Judith Landman‐Parker, Marie-Françoise Auclerc, et al.. (2000). Use of Recombinant Human Granulocyte Colony-Stimulating Factor to Increase Chemotherapy Dose-Intensity: A Randomized Trial in Very High-Risk Childhood Acute Lymphoblastic Leukemia. Journal of Clinical Oncology. 18(7). 1517–1524. 34 indexed citations
20.
Čech, Petr & Pierre Schneider. (1979). [Diabetes mellitus and infection. Impairement of granulocyte function (author's transl)].. PubMed. 68(36). 1135–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marı́a Niveiro Breakdown of academic impact, for papers by Thomas L. Cibull Breakdown of academic impact, for papers by Bénédicte Deau Breakdown of academic impact, for papers by Eun Bong Lee Breakdown of academic impact, for papers by Andre M. Kallab Breakdown of academic impact, for papers by Krista Kuuliala Breakdown of academic impact, for papers by Zimu Gong Breakdown of academic impact, for papers by H. Jouhadi Breakdown of academic impact, for papers by Pamela Ely Breakdown of academic impact, for papers by Ray Lonsdale
Rankless by CCL
2026